Membrane protein-driven drug development in Staphylococcus aureus: Bridging the gap in antibiotic efficacy for resistant strains | ||
| Microbes and Infectious Diseases | ||
| Article 13, Volume 5, Issue 4, November 2024, Pages 1367-1377 PDF (791.59 K) | ||
| Document Type: Review Article | ||
| DOI: 10.21608/mid.2024.260577.1744 | ||
| Authors | ||
| Kokila Manickam1; Suganya Kannan* 1; Jeyakumar Balakrishnan1; Guru aadavan Kuppusamy1; Gunasekaran Chinnathambi2 | ||
| 1Central Research Laboratory for Biomedical Research, Vinayaka Mission’s Medical College and Hospital, Vinayaka Mission’s Research Foundation (Deemed to be University), Karaikal, Puducherry, India | ||
| 2Vinayaka Mission’s Medical College and Hospital, Vinayaka Mission’s Research Foundation (Deemed to be University), Karaikal, Puducherry, India | ||
| Abstract | ||
| Background: The rising prevalence of the antibiotic-resistant strains of Staphylococcus aureus, notably to the Methicillin-resistant Staphylococcus aureus (MRSA), presents a critical challenge in contemporary healthcare. By examining the unique challenges posed by antibiotic-resistant strains, we underscore the urgent need for innovative therapeutic interventions. The review navigates the current landscape of antibiotic development, focusing on the exploitation of membrane proteins as viable targets for drug design. Membrane proteins in S. aureus, including adhesins, transporters, and signal transduction proteins, are dissected for their contributions to bacterial pathogenicity and resilience. The article elucidates the interplay between membrane proteins and antibiotic resistance, offering insights into the potential vulnerabilities that can be harnessed for drug development. Drawing attention to the multifaceted nature of membrane proteins, we discuss their critical roles in biofilm formation, nutrient acquisition, and evasion of host defences, underscoring their significance as druggable targets. In conclusion, this review critically examines the prospects and challenges of membrane protein-driven drug development in Staphylococcus aureus, highlighting the promising avenues for bridging the gap in antibiotic efficacy against resistant strains. The comprehensive exploration of this paradigm aims to inform and inspire researchers in the pursuit of innovative strategies to mitigate the looming threat to the antibiotic resistance in one of the most clinically significant bacterial pathogens. | ||
| Keywords | ||
| Staphylococcus auerus; Antibiotic resistance; Membrane proteins; Drug development; Antibiotic efficacy | ||
|
Statistics Article View: 626 PDF Download: 869 |
||
